Attovia Therapeutics has one itch-fighting drug in an early clinical trial, an eczema drug ready to enter testing in humans next year, and a third drug, aimed at inflammatory bowel diseases, in preclinical development.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
